Inside Forbes India

Podcast: The race to make a Covid-19 vaccine in India

05.22.2020 - By Forbes IndiaPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

It typically takes five years and about Rs 15 crore for just the first of many phases to introduce a viable vaccine to market. Companies across India such as Zydus Cadila, Serum Institute and Bharat Biotech are working against the clock to shrink this period down to a few months. Forbes India's Divya Shekhar takes a deep dive into what this rush looks like on the ground and gives us a glimpse into the path ahead in this episode

More episodes from Inside Forbes India